Patents by Inventor Sang-Soo Bang

Sang-Soo Bang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound for inhibiting TRPA1 function and use thereof
    Patent number: 8022050
    Abstract: The present invention relates to a TRPA1 activation inhibitor, more precisely a TRPA1 activity inhibitor containing isopentenyl pyrophosphate and a method for inhibiting pain containing the step of administering isopentenyl pyrophosphate to a subject. Isopentenyl pyrophosphate of the present invention can regulate pain caused by TRPA1, so that it can be effectively used for the development of a pain inhibitor which is effective but has less side effects.
    Type: Grant
    Filed: February 18, 2009
    Date of Patent: September 20, 2011
    Assignee: Korea University Industry and Academic Collaboration Foundation
    Inventors: Sun Wook Hwang, Sang-Soo Bang
  • Methods for screening for inhibitors of TRPV2 activation
    Patent number: 7915012
    Abstract: The present invention relates to a method for activation of TRPV2 (transient receptor potential vanilloid 2) using probenecid, more precisely a method for selecting a candidate for TRPV2 blocker using probenecid. Probenecid of the present invention works on TRPV2 specifically so that it facilitates the isolation of sensory neurons expressing TRPV2. Therefore, probenecid of the invention can be effectively used for the studies on TRPV2 mechanisms and the development of a TRPV2 based anodyne.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: March 29, 2011
    Assignee: Korea University Industry and Academic Collaboration Foundation
    Inventors: Sun Wook Hwang, Sang Soo Bang, Sang Heon Lee
  • Compound containing farnesyl diphosphate for modulating TRPV3 function and use thereof
    Patent number: 7763429
    Abstract: The present invention relates to a method for activating TRPV3 (transient receptor potential vanilloid 3) using FPP (farnesyl diphosphate) and a method for screening a TRPV3 activity inhibitor. FPP of the present invention has TRPV3 specific activity and therefore it can be effectively used for the study on TRPV3 mechanism and functions and for the development of a TRPV3 based pain reliever.
    Type: Grant
    Filed: February 18, 2009
    Date of Patent: July 27, 2010
    Assignee: Korea University Industry and Academic Collaboration Foundation
    Inventors: Sun Wook Hwang, Sang-Soo Bang
  • COMPOUND FOR INHIBITING TRPA1 FUNCTION AND USE THEREOF
    Publication number: 20100137259
    Abstract: The present invention relates to a TRPA1 activation inhibitor, more precisely a TRPA1 activity inhibitor containing isopentenyl pyrophosphate and a method for inhibiting pain containing the step of administering isopentenyl pyrophosphate to a subject. Isopentenyl pyrophosphate of the present invention can regulate pain caused by TRPA1, so that it can be effectively used for the development of a pain inhibitor which is effective but has less side effects.
    Type: Application
    Filed: February 18, 2009
    Publication date: June 3, 2010
    Applicant: Korea University Industry and Academic Collaboration Foundation
    Inventors: Sun Wook HWANG, Sang-Soo Bang
  • COMPOUND CONTAINING FARNESYL DIPHOSPHATE FOR MODULATING TRPV3 FUNCTION AND USE THEREOF
    Publication number: 20100136533
    Abstract: The present invention relates to a method for activating TRPV3 (transient receptor potential vanilloid 3) using FPP (farnesyl diphosphate) and a method for screening a TRPV3 activity inhibitor. FPP of the present invention has TRPV3 specific activity and therefore it can be effectively used for the study on TRPV3 mechanism and functions and for the development of a TRPV3 based pain reliever.
    Type: Application
    Filed: February 18, 2009
    Publication date: June 3, 2010
    Applicant: Korea University Industry and Academic Collaboration Foundation
    Inventors: Sun Wook HWANG, Sang-Soo Bang
  • COMPOUND FOR INHIBITING TRPV3 FUNCTION AND USE THEREOF
    Publication number: 20100137260
    Abstract: The present invention relates to a TRPV3 (transient receptor potential vanilloid 3) activity inhibitor, more precisely to a method for inhibiting TRPV3 activity including the step of treating isopentenyl pyrophosphate and a method for treating skin disease containing the step of administering isopentenyl pyrophosphate to a subject with skin disease or applying the same on the skin of the subject. Isopentenyl pyrophosphate of the present invention controls increase of sensory cell reactivity to current or migration and proliferation of skin cells induced by TRPV3, so that it can be effectively used for the development of a pain reliever or a therapeutic agent for skin disease.
    Type: Application
    Filed: February 18, 2009
    Publication date: June 3, 2010
    Applicant: Korea University Industry and Academic Collaboration Foundation
    Inventors: Sun Wook HWANG, Sang-Soo Bang
  • Activator for Transient Receptor Potential Vanilloid 2 Comprising Probenecids
    Publication number: 20090215107
    Abstract: The present invention relates to a method for activation of TRPV2 (transient receptor potential vanilloid 2) using probenecid, more precisely a method for selecting a candidate for TRPV2 blocker using probenecid. Probenecid of the present invention works on TRPV2 specifically so that it facilitates the isolation of sensory neurons expressing TRPV2. Therefore, probenecid of the invention can be effectively used for the studies on TRPV2 mechanisms and the development of a TRPV2 based anodyne.
    Type: Application
    Filed: August 21, 2008
    Publication date: August 27, 2009
    Applicant: Korea University, Anam-dong
    Inventors: Sun Wook Hwang, Sang Soo Bang, Sang Heon Lee